XML 27 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Financial Position - USD ($)
Mar. 31, 2025
Mar. 31, 2024
Current assets    
Cash and cash equivalents $ 6,135,166 $ 733,188
Restricted cash 35,964 29,611
Other receivables 137,348 41,747
Prepaid expense 251,796 322,126
Total current assets 6,560,274 1,126,672
Non-current assets    
Equipment 11,096 5,487
Investment in Psyence Labs Ltd 745,000
TOTAL ASSETS 7,316,370 1,132,159
Current liabilities    
Accounts payable and accrued liabilities 394,270 755,202
Convertible note liability 7,657,397
Derivative warrant liabilities 200,096 901,608
TOTAL LIABILITIES 594,366 12,104,699
SHAREHOLDERS EQUITY/(DEFICIT)    
Share Capital 61,752,305 46,125,397
Warrants Reserve 1,065,705
Accumulated Deficit (56,447,204) (57,458,994)
Reserves 351,198 361,057
TOTAL SHAREHOLDERS EQUITY/(DEFICIT) 6,722,004 (10,972,540)
TOTAL LIABILITIES AND NET EQUITY 7,316,370 1,132,159
NCAC Sponsor    
Current liabilities    
Due to related party 1,474,256
Psyence Group Inc    
Current liabilities    
Due to related party $ 1,316,236